Amygdalin
Created on 2024-08-13T18:46:33-05:00
Some preliminary evidence says Vitamin B17 could be a useful anti-cancer agent, however may have side effects that make people hesitant to proceed to full clinical trials.
Amygdalin has been reported to induce apoptosis of cancer cells, inhibiting cancer cells’ proliferation and slowing down tumor metastatic spread. However, only a few studies have been performed in in vivo animal models, while clinical studies remain even more scarce. The current evidence cannot support a recommendation of the use of nutritional supplements with amygdalin due to its cyano-moiety which exerts adverse side effects. Preliminary data have shown that the use of nanoparticles may be a promising alternative to enhance the anticancer effects of amygdalin while simultaneously reducing its adverse side effects.